Genes associated with the development of rheumatoid arthritis

No Pathway Network information available for Genes associated with the development of rheumatoid arthritis

Pathways in the Genes associated with the development of rheumatoid arthritis SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Genes associated with the development of rheumatoid arthritis SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Systemic lupus erythematosusEnrichmentBLK, CTLA4, HLA-DRB1, IRF5, PTPN22, STAT416.00
2Rheumatoid arthritisEnrichmentCD244, CIITA, IRF5, SLC22A49.55
3Diffuse cutaneous systemic sclerosisEnrichmentCCR6, HLA-DRB1, IRF57.71
4Limited sclerodermaEnrichmentCCR6, HLA-DRB1, IRF57.41
5Oligoarticular juvenile idiopathic arthritisEnrichmentIL2RA, PTPN22, STAT47.16
6Rheumatoid factor-negative juvenile idiopathic arthritisEnrichmentIL2RA, PTPN22, STAT47.16
7Vogt-koyanagi-harada diseaseEnrichmentHLA-DRB1, PTPN225.30
8Temporal arteritisEnrichmentHLA-DRB1, PTPN225.00
9Granulomatosis with polyangiitisEnrichmentCTLA4, PTPN224.60
10Type 1 diabetes mellitus 10EnrichmentIL2RA2.88
11Celiac disease 3EnrichmentCTLA42.88
12Stuve-wiedemann syndrome 2EnrichmentIL6ST2.88
13Hyper-ige syndrome 4a, autosomal dominant, with recurrent infectionsEnrichmentIL6ST2.88
14Disabling pansclerotic morphea of childhoodEnrichmentSTAT42.88
15Type 1 diabetes mellitus 12EnrichmentCTLA42.88
16Systemic lupus erythematosus 11EnrichmentSTAT42.88
17Pulmonary alveolar proteinosis, acquiredEnrichmentHLA-DRB12.88
18Systemic lupus erythematosus 10EnrichmentIRF52.88
19Immunodeficiency with hyper-igm, type 3EnrichmentCD402.88
20Inflammatory bowel disease 14EnrichmentIRF52.88
21Hyper-ige syndrome 4b, autosomal recessive, with recurrent infectionsEnrichmentIL6ST2.88
22Immunodeficiency 94 with autoinflammation and dysmorphic faciesEnrichmentIL6ST2.88
23Immune dysregulation, neurodevelopmental defects, and colitisEnrichmentITGAV2.88
24Hashimoto thyroiditisEnrichmentCTLA42.58
25Immunodeficiency 41 with lymphoproliferation and autoimmunityEnrichmentIL2RA2.58
26Maturity-onset diabetes of the young, type 11EnrichmentBLK2.58
27Sarcoidosis 1EnrichmentHLA-DRB12.58
28Bullous pemphigoidEnrichmentHLA-DRB12.58
29Pediatric multiple sclerosisEnrichmentHLA-DRB12.58
30Mycosis fungoidesEnrichmentCTLA42.40
31Stuve-wiedemann syndrome 1EnrichmentIL6ST2.40
32Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferationEnrichmentCTLA42.40
33Asparagine synthetase deficiencyEnrichmentCTLA42.40
34Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndromeEnrichmentCTLA42.40
35Adult-onset myasthenia gravisEnrichmentCTLA42.40
36Stüve-wiedemann syndromeEnrichmentIL6ST2.40
37Saczary syndromeEnrichmentCTLA42.40
38Immunodeficiency, common variable, 1EnrichmentCTLA42.28
39Pediatric systemic lupus erythematosusEnrichmentSTAT42.28
40Systemic-onset juvenile idiopathic arthritisEnrichmentHLA-DRB12.28
41Narcolepsy 2EnrichmentHLA-DRB12.18
42Follicular lymphomaEnrichmentHLA-DRB12.18
43Narcolepsy 1EnrichmentHLA-DRB11.98
44Primary biliary cholangitisEnrichmentIRF51.93
45Mhc class ii deficiencyEnrichmentCIITA1.93
46Mhc class ii deficiency 1EnrichmentCIITA1.84
47Multiple sclerosisEnrichmentHLA-DRB11.73
48Behcet syndromeEnrichmentSTAT41.60
49Maturity-onset diabetes of the youngEnrichmentBLK1.58
50Severe covid-19EnrichmentITGAV1.42

Loading...
Loading...
Loading...